About Pharma-Bio Serv
Pharma-Bio Serv is a company based in Dorado (United States) founded in 1993. Pharma-Bio Serv has raised $11.75 million across 1 funding round. Pharma-Bio Serv offers products and services including Quality Services, Regulatory Services, and Compliance Solutions. Pharma-Bio Serv operates in a competitive market with competitors including ProPharma Group, Validant, PharmaLex, Technical Safety Services and Celegence, among others.
- Headquarter Dorado, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Pharma-Bio Serv, Inc.
-
Annual Revenue
$9 M (USD)-5.34as on Oct 31, 2025
-
Net Profit
-$100.46 K (USD)87.08as on Oct 31, 2025
-
EBITDA
-$408.58 K (USD)63.07as on Oct 31, 2025
-
Total Equity Funding
$11.75 M (USD)
in 1 rounds
-
Latest Funding Round
$11.75 M (USD), Series A
Feb 01, 2006
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Pharma-Bio Serv
Pharma-Bio Serv offers a comprehensive portfolio of products and services, including Quality Services, Regulatory Services, and Compliance Solutions.
Delivers quality assurance for regulated manufacturing processes
Provides expertise in global regulatory standards like FDA and EMA
Offers integrated compliance support for product lifecycles
People of Pharma-Bio Serv
Unlock access to complete
Funding Insights of Pharma-Bio Serv
Pharma-Bio Serv has successfully raised a total of $11.75M through 1 strategic funding round. The most recent funding activity was a Series A round of $11.75 million completed in February 2006. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investments & Acquisitions by Pharma-Bio Serv
Investment portfolio details for Pharma-Bio Serv
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Pharma-Bio Serv
Detailed financials for Pharma-Bio Serv
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Pharma-Bio Serv Comparisons
Peer comparison for Pharma-Bio Serv
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Pharma-Bio Serv
Pharma-Bio Serv operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ProPharma Group, Validant, PharmaLex, Technical Safety Services and Celegence, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of regulatory compliance solutions to pharmaceutical, biotechnology and medical device
|
|
| Locked | Locked | Locked |
Regulatory, compliance, and quality consulting for GxP lifecycles is provided.
|
|
| Locked | Locked | Locked |
CRO specializing in regulatory affairs and pharmacovigilance
|
|
| Locked | Locked | Locked |
Healthcare instrumentation, medical gas systems, and related devices are manufactured.
|
|
| Locked | Locked | Locked |
Regulatory consulting and solutions for pharmaceuticals and medical devices compliance.
|
|
| Locked | Locked | Locked |
Regulatory support and consulting services are provided for clinical outcomes.
|
Detailed competitors of Pharma-Bio Serv
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Pharma-Bio Serv
Complete news archive for Pharma-Bio Serv
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Pharma-Bio Serv
Pharma-Bio Serv was founded in 1993 and raised its 1st funding round 13 years after it was founded.
Pharma-Bio Serv is headquartered in Dorado, United States. It is registered at Dorado, Puerto Rico, United States.
Pharma-Bio Serv is a funded company, having raised a total of $11.75M across 1 funding round to date.
Annual revenue of Pharma-Bio Serv is $9M as on Oct 31, 2025.
Pharma-Bio Serv was founded in 1993 and is headquartered in Dorado, Puerto Rico. Regulatory compliance, validation, and related support services are offered to life science industries. Operations focus on continuous compliance assurance, workforce enhancement for timely project delivery, risk management, and knowledge management. These services address regulated industry needs across various sectors.
Pharma-Bio Serv's top competitors include ProPharma Group, PharmaLex and Validant.
Pharma-Bio Serv offers Quality Services, Regulatory Services, and Compliance Solutions.